Metraipolis › archive › dc_ffd6616fa07a

Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy — Europe PMC PMID:35625950

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/35625950
DOI: 10.3390/biomedicines10051214
License (as archived): solo-consultazione
Archived: 2026-10-08T04:39:03.852Z
SHA-256 of the archived text: b81f5eecc99b1ac3f7df5706908a00f61b9fc4b16e7e269d46bc1ee2379cfcc9
Stable URL of this page: https://metraipolis.com/documento/dc_ffd6616fa07a

How to cite

Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy — Europe PMC PMID:35625950 — Europe PMC (en), https://europepmc.org/article/MED/35625950 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ffd6616fa07a (Metraipolis archive dc_ffd6616fa07a, sha256 b81f5eecc99b1ac3f7df5706908a00f61b9fc4b16e7e269d46bc1ee2379cfcc9)

BibTeX

@misc{dcffd6616fa07a,
  title = {Clinical Feasibility Study of Gold Nanoparticles as Theragnostic Agents for Precision Radiotherapy — Europe PMC PMID:35625950},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/35625950},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ffd6616fa07a; sha256 b81f5eecc99b1ac3f7df5706908a00f61b9fc4b16e7e269d46bc1ee2379cfcc9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/35625950. Agents can read the archived copy with the MCP tool read_document.